Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ratner

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Journal of Pediatric Orthopedics|March 1, 1987
Trabecular bone mineral density in idiopathic scoliosisS D Cook, A F Harding, E L Morgan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 4, 2009
Brain metastases in epithelial ovarian and primary peritoneal carcinomaElena S Ratner, Eugene Toy, David M O'Malley, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 7, 2018
Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapyJohn M Stahl, Jack M Qian, Christopher J Tien, et al.
Cancer Genetics and Cytogenetics|May 1, 1993
Chromosomal aberrations in two sporadic gastrinomasM E Herrmann, L L Rydstedt, G B Talpos, et al.
Gynecologic Oncology|March 21, 2015
Weekly ixabepilone with or without biweekly bevacizumab in the treatment of recurrent or persistent uterine and ovarian/primary peritoneal/fallopian tube cancers: A retrospective reviewDana M Roque, Elena S Ratner, Dan-Arin Silasi, et al.
Plos One|November 17, 2018
Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancerZ Ping Lin, Yong-Lian Zhu, Ying-Chun Lo, et al.
Gynecologic Oncology|June 15, 2010
MicroRNA signatures differentiate uterine cancer tumor subtypesElena S Ratner, David Tuck, Christine Richter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2018
Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic RearrangementStefania Bellone, Natalia Buza, Jungmin Choi, et al.
Gynecologic Oncology|October 30, 2016
Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective studyGary Altwerger, Gregory M Gressel, Diana P English, et al.
Journal of Translational Science|April 15, 2016
Cataloging antineoplastic agents according to their effectiveness against platinum-resistant and platinum-sensitive ovarian carcinoma cell linesKimiko Ishiguro, Yong-Lian Zhu, Z Ping Lin, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Journal of Pediatric Orthopedics|March 1, 1987
Trabecular bone mineral density in idiopathic scoliosisS D Cook, A F Harding, E L Morgan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 4, 2009
Brain metastases in epithelial ovarian and primary peritoneal carcinomaElena S Ratner, Eugene Toy, David M O'Malley, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 7, 2018
Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapyJohn M Stahl, Jack M Qian, Christopher J Tien, et al.
Cancer Genetics and Cytogenetics|May 1, 1993
Chromosomal aberrations in two sporadic gastrinomasM E Herrmann, L L Rydstedt, G B Talpos, et al.
Gynecologic Oncology|March 21, 2015
Weekly ixabepilone with or without biweekly bevacizumab in the treatment of recurrent or persistent uterine and ovarian/primary peritoneal/fallopian tube cancers: A retrospective reviewDana M Roque, Elena S Ratner, Dan-Arin Silasi, et al.
Plos One|November 17, 2018
Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancerZ Ping Lin, Yong-Lian Zhu, Ying-Chun Lo, et al.
Gynecologic Oncology|June 15, 2010
MicroRNA signatures differentiate uterine cancer tumor subtypesElena S Ratner, David Tuck, Christine Richter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2018
Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic RearrangementStefania Bellone, Natalia Buza, Jungmin Choi, et al.
Gynecologic Oncology|October 30, 2016
Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective studyGary Altwerger, Gregory M Gressel, Diana P English, et al.
Journal of Translational Science|April 15, 2016
Cataloging antineoplastic agents according to their effectiveness against platinum-resistant and platinum-sensitive ovarian carcinoma cell linesKimiko Ishiguro, Yong-Lian Zhu, Z Ping Lin, et al.
Pageof 11